IOYIF

July 29-31, 2021 • Drs. Mario Sznol, Cath Bollard • Partner @sitcancer • Presented by @cec_onc • Grant: AstraZeneca

[NatlBlkChrchInitive @NBCIBlackChurch]

Opioid Early Career Scholar Program⁠
⁠
An intensive multi-day opioid REMS initiative in Pain Management⁠
⁠
Register Today⁠
⁠
Early Bird Deadline: February 14th⁠
March 15-16, 2025⁠
Wyndham Garden Lake Buena Vista ⁠
Buena Vista, FL⁠
⁠
@cmeoutfitters #health #wellness

[Faisal Scientist @zaidheartsci]

@CEC_Onc @PGrivasMDPhD @DanielPetrylak Must-attend for oncologists and urologists! Excited to expand my knowledge on ADCs and adverse events. #CME #MedEd

[Breath of Hope Kentucky @breathofhopeky]

Keeping these young investigators engaged & supported in their important work gives patients continued hope for a better tomorrow. Our future depends on progress. We are thankful for these mentors and this platform! @EGFRSummit #ResearchMatters #anyonewithlungs

[IOYIF @IOYIForum]

#ALLYIF2023 DAY 1

[EGFR Resisters Research Summit @EGFRSummit]

#ALLYIF2023 DAY 1

[Dr. Jessica Giddens DNP (nurse) @DrJGiddensRN]

https://t.co/8C4xcHHv3D @cmeoutfitters #MedEd #MedTwitter #healthcare Learn more about what makes CME education different from other routes of learning.

[IOYIF @IOYIForum]

Looking to present your research??

[ALLYIForum @ALLYIForum]

Submit your abstract for the #ALLYIF 2023!

📈 Improve your #Research Skills
🏆 Research awards range from $1k-$4k

DEADLINE to submit is OCTOBER 15➡ https://t.co/U4PWRwCPxK

#HematologyResearch #OncologyResearch

[IOYIF @IOYIForum]

Look at who ran into each in the wild at #ASCO23? 2⃣ fantastic #IOYIF21 alumni! @BraunMDPhD @thenasheffect 🙌

[David Braun @BraunMDPhD]

Lucky to run into old friends @thenasheffect from our time @IOYIForum #ASCO23

[IOYIF @IOYIForum]

Immuno-oncology Young Investigators! Join us LIVE online or in-person at #SITC22 Nov 11th at 6:00pm ET & earn 1.0 CME Credit!

Our faculty panel will discuss the power of immunotherapy in HCC & BTC!

Register for in-person/online here ➡️ https://t.co/cKuVN369uX

[Juan C Osorio MD @juanosoriomd]

Extremely grateful @BWFUND for the support!!! Also thankful for the amazing mentorship, it really makes a difference. Also congrats to all the fellow awardees!

[IOYIF @IOYIForum]

Excited to see so many @IOYIForum faculty & alums involved with this @sitcancer series! @MSznol @Vignali_Lab @BcellBruno @aaronmring #LAG3 #IL18 #TIL #Bcell
https://t.co/90ujaVDvig

[IOYIF @IOYIForum]

Shout out to an amazing @IOYIForum alum, @thenasheffect! 🎉🎉

[Rafeh Naqash, MD, FASCO @thenasheffect]

Honored to be part of and learn from this group of featured voices @ASCO. Will try my best to highlight #ASCO22 sessions on Dev Therapeutics/ IO Biomarkers/ irAEs/ Lung. @ShannonWestin @neerajaiims @DrBetofMDPhD @crisbergerot @AnaVManana @fumikochino @IshwariaMD others

[Dionisia Quiroga, DO, PhD, FASCO @quirogad]

Honored to be included as an ASCO YIA recipient this year for my work on systemic inflammation in people experiencing #lymphedema following breast cancer tx!
Also so happy to be sharing this experience with @OSUCCC_James co-fellows @JasmineSukumar & Nate Denlinger!

[David Braun @BraunMDPhD]

The Center of Molecular and Cellular Oncology (CMCO) @YaleMed @YaleCancer is hiring a Program Manager!

https://t.co/kuT1S5Om5g

[IOYIF @IOYIForum]

Congrats to our alumni and awardee, @BraunMDPhD! 🎉 #IOYIF21

[The ASCO Post @ASCOPost]

David Braun, MD, PhD, Joins Prostate and Urologic Cancers Program at Yale Cancer Center https://t.co/qfIbDPpf2O @YaleCancer @BraunMDPhD

[IOYIF @IOYIForum]

Congrats @thenasheffect on the nomination! Proud to see our alums being recognized! Be sure to congratulate Dr. Naquash at ASCO! 🙌🙌🙌

[Rafeh Naqash, MD, FASCO @thenasheffect]

Deeply honored to have been nominated and selected for 2022 class of #40 under #40 in Oncology 🙂 @StephensonCC @OUHealth @sitcancerECS
Join us for the reception and ceremony on June 4 #ASCO22 😊

[Jennifer Guerriero, PhD @JennGuerriero]

Thank you #AACR2022 for an incredible week of science, friends and food. You even brought #Tcells and #macrophages together.
Heard among friends in this photo: “it’s not all about the Tcell”. @JimAllisonPhD @MiriamMerad @PamSharmaMDPhD

[Vignali Lab @Vignali_Lab]

So excited to see FDA approval of the first anti-LAG3, in combination with anti-PD1! It has been a long road but we have had the pleasure of working with an amazing team of trainees and collaborators dissecting LAG3 function since ~2020 (20+ papers)! 1/2 https://t.co/bOiY4GaCHG

[David Braun @BraunMDPhD]

Out in @NEJM this week, our perspective on some recent outstanding work defining the phenotype of tumor-infiltrating T cells across cancer types, and our thoughts on next steps.

Tumor-Infiltrating T Cells — A Portrait | NEJM https://t.co/WoAI49kbFT

@YaleCancer @YaleMed

[EGFR Resisters Research Summit @EGFRSummit]

We would like to extend a THANK YOU to Rosemary Ostmann from @rosecomm & @ivybelkins from @EGFRResisters for sharing all of their insights on best practices to becoming a digital opinion leader during last Friday’s webinar. 💻🔎

See a few of the topics below! #DOL #MedTwitter

[IOYIF @IOYIForum]

Our webinar on best practices to becoming a digital opinion leader is this Fri 1/21 @ 12p!

Reply to this tweet w/ your Q's on best practices as a trusted source & hear from communications expert @rosecomm answer your Q's.

Click ⬇️ & reserve your spot!
https://t.co/iVuwKO53uV

[IOYIF @IOYIForum]

Hey YIF Alums!

What are you most curious about in becoming a trusted source for science in the age of digital media? 🤔Join us on Fri 1/21 @ 12p to see how you can increase the reach of your research.🌐

Click ⬇️to register for this can’t miss session!
https://t.co/iVuwKOmEmt